Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$0.27 - $0.5 $16,632 - $30,800
-61,600 Reduced 51.44%
58,145 $16,000
Q4 2021

Jan 31, 2022

BUY
$0.34 - $0.86 $20,767 - $52,528
61,080 Added 104.12%
119,745 $61,000
Q2 2021

Aug 11, 2021

BUY
$0.48 - $0.72 $19 - $28
40 Added 0.07%
58,665 $35,000
Q4 2020

Feb 11, 2021

SELL
$0.38 - $0.78 $31,846 - $65,368
-83,806 Reduced 58.84%
58,625 $39,000
Q3 2020

Nov 05, 2020

SELL
$0.47 - $0.64 $16,450 - $22,400
-35,000 Reduced 19.73%
142,431 $67,000
Q2 2020

Aug 12, 2020

BUY
$0.41 - $0.73 $14,145 - $25,185
34,500 Added 24.14%
177,431 $90,000
Q1 2020

May 11, 2020

BUY
$0.36 - $0.79 $13,320 - $29,230
37,000 Added 34.93%
142,931 $60,000
Q4 2019

Feb 05, 2020

BUY
$0.75 - $0.89 $21,588 - $25,618
28,785 Added 37.31%
105,931 $82,000
Q3 2019

Oct 30, 2019

BUY
$0.78 - $1.09 $19,427 - $27,148
24,907 Added 47.68%
77,146 $70,000
Q2 2019

Jul 19, 2019

BUY
$0.98 - $1.64 $34,558 - $57,832
35,264 Added 207.74%
52,239 $60,000
Q4 2018

Feb 11, 2019

BUY
$0.63 - $1.0 $504 - $800
800 Added 4.95%
16,975 $12,000
Q3 2018

Nov 06, 2018

SELL
$0.88 - $1.1 $3,806 - $4,757
-4,325 Reduced 21.1%
16,175 $16,000
Q2 2018

Jul 31, 2018

SELL
$0.91 - $1.45 $1,255 - $2,001
-1,380 Reduced 6.31%
20,500 $20,000
Q1 2018

May 14, 2018

BUY
$0.84 - $1.18 $1,680 - $2,360
2,000 Added 10.06%
21,880 $23,000
Q4 2017

Feb 12, 2018

BUY
$0.68 - $1.0 $13,518 - $19,880
19,880
19,880 $17,000

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0

About PALATIN TECHNOLOGIES INC


  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $8.83M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.